Boston Children's Hospital Letter Regarding the Bovine Pericardial Bioprosthetic Valve

The ACC has received a letter from Boston Children’s Hospital regarding the Bovine Pericardial (Mitroflow) Bioprosthetic Valve. The ACC has been, and will continue to be, in contact with the Food and Drug Administration (FDA) on this matter and will provide any updates to members as they are available.

Keywords: Heart Valve Prosthesis, United States Food and Drug Administration, Bioprosthesis, United States

< Back to Listings